RELIANCE Study to Prevent COPD Exacerbations

I'm Interested!

RofLumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: Yes
Type: Interventional / Therapeutic
Trial Phase: Phase III
Conditions Being Studied: Chronic Obstructive Pulmonary Disease (COPD)

Study Purpose

The purpose of this study is to compare two drugs, Azithromycin or Roflumilast, that doctors are planning to prescribe for their patients with Chronic Obstructive Pulmonary Disease.

Who Can Participate

Participants 40 years or older diagnosed with Chronic Obstructive Pulmonary Disease whose physician plans to presecribe Azithromycin or Roflumilast may be eligible for this study.

Principal Investigator
Catalina Teba MD

Department/Division
Medicine (Pulmonary and Critical Care Medicine)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00000081
StudyID: SITE00000081
ClinicalTrials.gov: NCT04069312

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422